Surveillance of hepatocellular carcinoma using liver stiffness in patients with hepatitis C after sustained virologic response by direct-acting antivirals-Reference-Cited by-同舟云学术

Surveillance of hepatocellular carcinoma using liver stiffness in patients with hepatitis C after sustained virologic response by direct-acting antivirals

Published:2022-06-01 Issue:6 Volume:63 Page:268-278
ISSN:0451-4203
Container-title:Kanzo
language:en
Short-container-title:Acta hepatologica Japonica

Author:

Hirashima Noboru¹,Shimada Masaaki¹,Urata Noboru¹,Saito Masashi¹

Affiliation:

1. Department of Gastroenterology, National Hospital Organization Nagoya Medical Center

Publisher

Japan Society of Hepatology

Subject

Hepatology

Link

https://www.jstage.jst.go.jp/article/kanzo/63/6/63_268/_pdf

Reference36 articles.

1. 1) Lawitz E, Gane E, Pearlman B, et al. Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for HCV virus genotype 1 infection in previously untreated patients with cirrhosis and patients with previous null response with or without cirrhosis (C-WORTHY): a randomized, open-label phase 2 trial. Lancet 2015; 385: 1075-1086

2. 2) Afdhal N, Reddy KR, Nelson DR, et al. Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection. N Engl J Med 2014; 370: 1483-1493

3. 3) Kumada H, Suzuki Y, Ikeda K, et al. Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection. Hepatology 2014; 59: 2083-2091

4. 4) Chayama K, Notsumata K, Kurosaki M, et al. Randomized trial of interferon- and ribavirin-free ombitasvir/paritaprevir/ritonavir in treatment-experienced hepatitis c virus-infected patients. Hepatology 2015; 61: 1523-1532

5. 5) Zeuzem S, Dusheiko GM, salupere R, et al. Sofosbuvir and ribavirin in HCV genotype 2 and 3. N Eng J Med 2014; 370: 1993-2001

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Follow-up and estimation of steatotic liver disease using transient elastography in patients with human immunodeficiency virus;Kanzo;2024-04-01